Lamotrigine
Back to searchMolecule Structure
Scientific Name
Lamotrigine
Description of the Drug
Lamotrigine is a phenyltriazine antiepileptic used to treat some types of epilepsy and bipolar I disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00555
http://www.drugbank.ca/drugs/DB00555
Brand Name(s)
Lamictal, Lamictal cd, Lamictal odt, Lamictal xr, Lamotrigine
Company Owner(s)
Cipla Ltd, Alkem Laboratories Ltd, Jubilant Generics Ltd, Watson Laboratories Inc, Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Glaxosmithkline Llc, Atlantide Pharmaceuticals Ag, Amneal Pharmaceuticals Of New York Llc, Impax Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35439 | |
| PharmGKB | PA450164 | |
| Human Metabolome Database | HMDB0014695 | |
| DrugBank | DB00555 | |
| PubChem: Thomson Pharma | 14823602 | |
| PubChem | 3878 | |
| Mcule | MCULE-7648410888 | |
| LINCS | LSM-4104 | |
| Nikkaji | J25.814H | |
| BindingDB | 50031299 | |
| EPA CompTox Dashboard | DTXSID2023195 | |
| DrugCentral | 1540 | |
| Brenda | 169768 | 7741 |
| ChemicalBook | CB4166704 | |
| Guide to Pharmacology | 2622 | |
| rxnorm | LAMOTRIGINE | LAMICTAL |
| PubChem: Drugs of the Future | 12013463 | |
| ChEBI | 6367 | |
| ZINC | ZINC000000013156 |
